ASCP, working in collaboration with Q Synthesis LLC, invites pathologists to participate in a unique cohort-based leadership development CME program called Pathology Trailblazers: HER2-low Breast Cancer Collaborative Learning Exchange.
This program will begin in May 2022 and run for approximately 3 months. Pathology Trailblazers: HER2-low Breast Cancer Collaborative Learning Exchange is designed to:
Learn more about this unique program here: https://www.ascp.org/content/learning/breast-cancer#trailblazers Comments are closed.
|
Author@DrJosephKim Sign up to receive updates:
|